UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	Interventional radiology clinical practice guidelines need higher quality systematic reviews
Title of the study (Brief title)	Reporting guidelines in interventional radiology
Region	Japan

Condition
Condition	clinical practice guidelines
Classification by specialty	Radiology
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To evaluate, using AMSTAR and PRISMA assessment tools, the methodological quality and transparency of reporting in systematic reviews of various study designs that are used as evidence in interventional radiology clinical practice guidelines for neurovascular disorders from the Society of Interventional Radiology.
Basic objectives2	Others
Basic objectives -Others	See above.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	The PRISMA and AMSTAR scores for systematic reviews underlying interventional radiology clinical practice guidelines.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type	Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit	Not applicable
Age-upper limit	Not applicable
Gender	Male and Female
Key inclusion criteria	If the clinical practice guideline was: 1) it was recognized by a national government or provider/professional organization and contains recommendations for best practices within Neurovascular Interventional Radiology; 2) it was written in English. If the systematic review: 1) was reported as a systematic review or meta-analysis; 2) was reported in English; 3) was peer-reviewed and published or currently in press; 4) it performed a systematic search and synthesis of available evidence.
Key exclusion criteria	A clinical practice guideline was excluded if: 1) it lacked a reference list or if the reference list was not readily accessible (e.g. it is only available by email correspondence). A systematic review was excluded if :1) it did not meet the inclusion criteria; 2) it was a review of animal studies.
Target sample size	65

Research contact person
Name of lead principal investigator	A. Benjamin Chong
Organization	Oklahoma State University Center for Health Sciences
Division name	College of Osteopathic Medicine
Address	1111 W 17th St, Tulsa, OK 74104 USA
TEL	+1-918-606-7674
Email	achong@okstate.edu

Public contact
Name of contact person	Matt Vassar
Organization	Oklahoma State University Center for Health Sciences
Division name	College of Osteopathic Medicine
Address	1111 W 17th St, Tulsa, OK 74107 USA
TEL	+1-918-645-9253
Homepage URL
Email	matt.vassar@okstate.edu

Sponsor
Institute	Oklahoma State University Center for Health Sciences - College of Osteopathic Medicine
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization	n/a
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2016 Year 07 Month 27 Day

Progress
Recruitment status	Completed
Date of protocol fixation	2016 Year 07 Month 05 Day
Anticipated trial start date	2016 Year 07 Month 05 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results	Unpublished
URL releasing results
Results
Other related information	systematic review

Management information
Registered date	2016 Year 07 Month 27 Day
Last modified on	2016 Year 07 Month 27 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026909